D
MedX Health Corp
MDX.V
TSX
D
Sell
2/7/2025Upgraded
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 2/7/2025 due to a noticeable increase in the volatility index and total return index.
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 2/7/2025 due to a noticeable increase in the volatility index and total return index.
E
Sell
1/23/2025Downgrade
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 1/23/2025 due to a decline in the volatility index and valuation index.
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 1/23/2025 due to a decline in the volatility index and valuation index.
D
Sell
1/8/2025Upgraded
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 1/8/2025 due to an increase in the volatility index, total return index and valuation index.
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 1/8/2025 due to an increase in the volatility index, total return index and valuation index.
E
Sell
12/23/2024Downgrade
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 12/23/2024 due to a decline in the volatility index.
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 12/23/2024 due to a decline in the volatility index.
D
Sell
12/6/2024Upgraded
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 12/6/2024 due to a noticeable increase in the total return index, growth index and volatility index. EBIT increased 33.64% from -$538.1 to -$357.1, earnings per share increased from -$0.0026 to -$0.0019, and operating cash flow increased 7.52% from -$554.2 to -$512.5.
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 12/6/2024 due to a noticeable increase in the total return index, growth index and volatility index. EBIT increased 33.64% from -$538.1 to -$357.1, earnings per share increased from -$0.0026 to -$0.0019, and operating cash flow increased 7.52% from -$554.2 to -$512.5.
E
Sell
11/11/2024Downgrade
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 11/11/2024 due to a decline in the volatility index and growth index.
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 11/11/2024 due to a decline in the volatility index and growth index.
D
Sell
10/25/2024Upgraded
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 10/25/2024 due to an increase in the volatility index and total return index.
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 10/25/2024 due to an increase in the volatility index and total return index.
E
Sell
9/30/2024Downgrade
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 9/30/2024 due to a decline in the volatility index and valuation index.
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 9/30/2024 due to a decline in the volatility index and valuation index.
D
Sell
9/12/2024Upgraded
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 9/12/2024 due to an increase in the volatility index and total return index.
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 9/12/2024 due to an increase in the volatility index and total return index.
E
Sell
8/29/2024Downgrade
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 8/29/2024 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.04 to 0.03.
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 8/29/2024 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.04 to 0.03.
D
Sell
4/11/2024Upgraded
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 4/11/2024 due to an increase in the total return index and volatility index.
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 4/11/2024 due to an increase in the total return index and volatility index.
E
Sell
2/26/2024Downgrade
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 2/26/2024 due to a decline in the total return index and volatility index.
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 2/26/2024 due to a decline in the total return index and volatility index.
D
Sell
2/7/2024Upgraded
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 2/7/2024 due to an increase in the volatility index and valuation index.
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 2/7/2024 due to an increase in the volatility index and valuation index.
E
Sell
9/27/2023Downgrade
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 9/27/2023 due to a decline in the volatility index, valuation index and solvency index. The quick ratio declined from 0.11 to 0.04, and debt to equity increased from -0.82 to -0.77.
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 9/27/2023 due to a decline in the volatility index, valuation index and solvency index. The quick ratio declined from 0.11 to 0.04, and debt to equity increased from -0.82 to -0.77.
D
Sell
4/4/2023Upgraded
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 4/4/2023 due to an increase in the volatility index and total return index.
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 4/4/2023 due to an increase in the volatility index and total return index.
E
Sell
3/20/2023Downgrade
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 3/20/2023 due to a decline in the volatility index.
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 3/20/2023 due to a decline in the volatility index.
D
Sell
3/14/2023Downgrade
MedX Health Corp (MDX.V) was downgraded to D- from D on 03/14/2023.
MedX Health Corp (MDX.V) was downgraded to D- from D on 03/14/2023.
D
Sell
2/9/2023Upgraded
MedX Health Corp (MDX.V) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
MedX Health Corp (MDX.V) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
MedX Health Corp (MDX.V) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index.
MedX Health Corp (MDX.V) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index.
D
Sell
2/7/2023Upgraded
MedX Health Corp (MDX.V) was upgraded to D from D- on 2/7/2023 due to an increase in the volatility index and growth index. EBIT increased 16.19% from -$803.4 to -$673.3, and earnings per share increased from -$0.0057 to -$0.005.
MedX Health Corp (MDX.V) was upgraded to D from D- on 2/7/2023 due to an increase in the volatility index and growth index. EBIT increased 16.19% from -$803.4 to -$673.3, and earnings per share increased from -$0.0057 to -$0.005.
D
Sell
5/4/2022Upgraded
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 5/4/2022 due to an increase in the growth index, solvency index and valuation index. Total revenue increased 126.1% from $74.7 to $168.9, operating cash flow increased 33.7% from -$873.6 to -$579.2, and EBIT increased 19.48% from -$1.1M to -$887.6.
MedX Health Corp (MDX.V) was upgraded to D- from E+ on 5/4/2022 due to an increase in the growth index, solvency index and valuation index. Total revenue increased 126.1% from $74.7 to $168.9, operating cash flow increased 33.7% from -$873.6 to -$579.2, and EBIT increased 19.48% from -$1.1M to -$887.6.
E
Sell
4/20/2022Downgrade
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
MedX Health Corp (MDX.V) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
12/3/2021Downgrade
MedX Health Corp (MDX.V) was downgraded to D- from D on 12/3/2021 due to a decline in the growth index, total return index and volatility index. Total revenue declined 37.38% from $119.3 to $74.7, earnings per share declined from -$0.0056 to -$0.0068, and EBIT declined 20.92% from -$911.6 to -$1.1M.
MedX Health Corp (MDX.V) was downgraded to D- from D on 12/3/2021 due to a decline in the growth index, total return index and volatility index. Total revenue declined 37.38% from $119.3 to $74.7, earnings per share declined from -$0.0056 to -$0.0068, and EBIT declined 20.92% from -$911.6 to -$1.1M.
D
Sell
11/23/2021Upgraded
MedX Health Corp (MDX.V) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
MedX Health Corp (MDX.V) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
MedX Health Corp (MDX.V) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the growth index and volatility index. EBIT declined 23.31% from -$739.3 to -$911.6, and earnings per share declined from -$0.0046 to -$0.0056.
MedX Health Corp (MDX.V) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the growth index and volatility index. EBIT declined 23.31% from -$739.3 to -$911.6, and earnings per share declined from -$0.0046 to -$0.0056.
D
Sell
5/1/2020Downgrade
MedX Health Corp (MDX.V) was downgraded to D from C- on 5/1/2020 due to a significant decline in the efficiency index, solvency index and valuation index.
MedX Health Corp (MDX.V) was downgraded to D from C- on 5/1/2020 due to a significant decline in the efficiency index, solvency index and valuation index.
C
Hold
3/27/2020Upgraded
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 3/27/2020 due to an increase in the volatility index, total return index and valuation index.
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 3/27/2020 due to an increase in the volatility index, total return index and valuation index.
D
Sell
3/12/2020Downgrade
MedX Health Corp (MDX.V) was downgraded to D+ from C- on 3/12/2020 due to a decline in the volatility index and total return index.
MedX Health Corp (MDX.V) was downgraded to D+ from C- on 3/12/2020 due to a decline in the volatility index and total return index.
C
Hold
2/26/2020Upgraded
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 2/26/2020 due to an increase in the volatility index and growth index. Operating cash flow increased 59.58% from -$317.9 to -$128.5, earnings per share increased from -$0.0039 to -$0.0031, and EBIT increased 20.36% from -$514.7 to -$409.9.
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 2/26/2020 due to an increase in the volatility index and growth index. Operating cash flow increased 59.58% from -$317.9 to -$128.5, earnings per share increased from -$0.0039 to -$0.0031, and EBIT increased 20.36% from -$514.7 to -$409.9.
D
Sell
9/30/2019Downgrade
MedX Health Corp (MDX.V) was downgraded to D+ from C- on 9/30/2019 due to a decline in the total return index and volatility index.
MedX Health Corp (MDX.V) was downgraded to D+ from C- on 9/30/2019 due to a decline in the total return index and volatility index.
C
Hold
9/6/2019Upgraded
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 9/6/2019 due to an increase in the growth index.
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 9/6/2019 due to an increase in the growth index.
D
Sell
8/29/2019Upgraded
MedX Health Corp (MDX.V) was upgraded to D+ from D on 8/29/2019 due to a significant increase in the efficiency index and growth index. Total revenue increased 39.35% from $139 to $193.7, net income increased 9.06% from -$592.8 to -$539.1, and EBIT increased 8.64% from -$563.4 to -$514.7.
MedX Health Corp (MDX.V) was upgraded to D+ from D on 8/29/2019 due to a significant increase in the efficiency index and growth index. Total revenue increased 39.35% from $139 to $193.7, net income increased 9.06% from -$592.8 to -$539.1, and EBIT increased 8.64% from -$563.4 to -$514.7.
D
Sell
5/31/2019Downgrade
MedX Health Corp (MDX.V) was downgraded to D from C- on 5/31/2019 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 0.08 to 0.03, total revenue declined 33.33% from $208.5 to $139, and earnings per share declined from -$0.0057 to -$0.0075.
MedX Health Corp (MDX.V) was downgraded to D from C- on 5/31/2019 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 0.08 to 0.03, total revenue declined 33.33% from $208.5 to $139, and earnings per share declined from -$0.0057 to -$0.0075.
C
Hold
8/24/2018Upgraded
MedX Health Corp (MDX.V) was upgraded to C- from D on 8/24/2018 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 75.84% from $178.8 to $314.4, and operating cash flow increased 18.74% from -$694.8 to -$564.6.
MedX Health Corp (MDX.V) was upgraded to C- from D on 8/24/2018 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 75.84% from $178.8 to $314.4, and operating cash flow increased 18.74% from -$694.8 to -$564.6.
D
Sell
7/3/2018Downgrade
MedX Health Corp (MDX.V) was downgraded to D from D+ on 7/3/2018 due to a large decline in the total return index and volatility index.
MedX Health Corp (MDX.V) was downgraded to D from D+ on 7/3/2018 due to a large decline in the total return index and volatility index.
D
Sell
6/5/2018Downgrade
MedX Health Corp (MDX.V) was downgraded to D+ from C on 6/5/2018 due to a significant decline in the efficiency index, total return index and growth index. Operating cash flow declined 144.91% from -$283.7 to -$694.8, EBIT declined 137.11% from -$212.6 to -$504.1, and net income declined 123.74% from -$237.6 to -$531.6.
MedX Health Corp (MDX.V) was downgraded to D+ from C on 6/5/2018 due to a significant decline in the efficiency index, total return index and growth index. Operating cash flow declined 144.91% from -$283.7 to -$694.8, EBIT declined 137.11% from -$212.6 to -$504.1, and net income declined 123.74% from -$237.6 to -$531.6.
C
Hold
5/2/2018Upgraded
MedX Health Corp (MDX.V) was upgraded to C from C- on 5/2/2018 due to a significant increase in the total return index, growth index and efficiency index. EBIT increased 49.59% from -$421.7 to -$212.6, earnings per share increased from -$0.0041 to -$0.0022, and net income increased 45.96% from -$439.7 to -$237.6.
MedX Health Corp (MDX.V) was upgraded to C from C- on 5/2/2018 due to a significant increase in the total return index, growth index and efficiency index. EBIT increased 49.59% from -$421.7 to -$212.6, earnings per share increased from -$0.0041 to -$0.0022, and net income increased 45.96% from -$439.7 to -$237.6.
C
Hold
8/31/2016Upgraded
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 8/31/2016 due to an increase in the volatility index, total return index and valuation index.
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 8/31/2016 due to an increase in the volatility index, total return index and valuation index.
D
Sell
8/17/2016Downgrade
MedX Health Corp (MDX.V) was downgraded to D+ from C- on 8/17/2016 due to a decline in the volatility index and valuation index.
MedX Health Corp (MDX.V) was downgraded to D+ from C- on 8/17/2016 due to a decline in the volatility index and valuation index.
C
Hold
8/1/2016Upgraded
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 8/1/2016 due to an increase in the volatility index and total return index.
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 8/1/2016 due to an increase in the volatility index and total return index.
D
Sell
6/1/2016Downgrade
MedX Health Corp (MDX.V) was downgraded to D+ from C- on 6/1/2016 due to a large decline in the growth index, valuation index and volatility index. Operating cash flow declined 537.9% from $12.4 to -$54.3, total revenue declined 45.87% from $254.4 to $137.7, and earnings per share declined from -$0.0016 to -$0.002.
MedX Health Corp (MDX.V) was downgraded to D+ from C- on 6/1/2016 due to a large decline in the growth index, valuation index and volatility index. Operating cash flow declined 537.9% from $12.4 to -$54.3, total revenue declined 45.87% from $254.4 to $137.7, and earnings per share declined from -$0.0016 to -$0.002.
C
Hold
5/17/2016Downgrade
MedX Health Corp (MDX.V) was downgraded to C- from C on 5/17/2016 due to a large decline in the total return index and volatility index.
MedX Health Corp (MDX.V) was downgraded to C- from C on 5/17/2016 due to a large decline in the total return index and volatility index.
C
Hold
5/2/2016Upgraded
MedX Health Corp (MDX.V) was upgraded to C from C- on 5/2/2016 due to a noticeable increase in the growth index, efficiency index and total return index. Operating cash flow increased 103.48% from -$356.2 to $12.4, total revenue increased 100.47% from $126.9 to $254.4, and earnings per share increased from -$0.0026 to -$0.0016.
MedX Health Corp (MDX.V) was upgraded to C from C- on 5/2/2016 due to a noticeable increase in the growth index, efficiency index and total return index. Operating cash flow increased 103.48% from -$356.2 to $12.4, total revenue increased 100.47% from $126.9 to $254.4, and earnings per share increased from -$0.0026 to -$0.0016.
C
Hold
3/28/2016Upgraded
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 3/28/2016 due to a large increase in the total return index.
MedX Health Corp (MDX.V) was upgraded to C- from D+ on 3/28/2016 due to a large increase in the total return index.
D
Sell
3/11/2016Downgrade
MedX Health Corp (MDX.V) was downgraded to D+ from C- on 3/11/2016 due to a large decline in the volatility index and total return index.
MedX Health Corp (MDX.V) was downgraded to D+ from C- on 3/11/2016 due to a large decline in the volatility index and total return index.
C
Hold
3/1/2016Downgrade
MedX Health Corp (MDX.V) was downgraded to C- from C on 3/1/2016 due to a substantial decline in the total return index and volatility index.
MedX Health Corp (MDX.V) was downgraded to C- from C on 3/1/2016 due to a substantial decline in the total return index and volatility index.
C
Hold
11/27/2015Downgrade
MedX Health Corp (MDX.V) was downgraded to C from C+ on 11/27/2015 due to a substantial decline in the valuation index, growth index and solvency index. The quick ratio declined from 0.22 to 0.03, and total revenue declined 57.52% from $298.7 to $126.9.
MedX Health Corp (MDX.V) was downgraded to C from C+ on 11/27/2015 due to a substantial decline in the valuation index, growth index and solvency index. The quick ratio declined from 0.22 to 0.03, and total revenue declined 57.52% from $298.7 to $126.9.
C
Hold
11/2/2015Downgrade
MedX Health Corp (MDX.V) was downgraded to C+ from B- on 11/2/2015 due to a large decline in the total return index and volatility index.
MedX Health Corp (MDX.V) was downgraded to C+ from B- on 11/2/2015 due to a large decline in the total return index and volatility index.
B
Buy
10/14/2015Upgraded
MedX Health Corp (MDX.V) was upgraded to B- from C+ on 10/14/2015 due to a significant increase in the total return index.
MedX Health Corp (MDX.V) was upgraded to B- from C+ on 10/14/2015 due to a significant increase in the total return index.
C
Hold
8/28/2015Upgraded
MedX Health Corp (MDX.V) was upgraded to C+ from C on 8/28/2015 due to a significant increase in the volatility index, valuation index and total return index.
MedX Health Corp (MDX.V) was upgraded to C+ from C on 8/28/2015 due to a significant increase in the volatility index, valuation index and total return index.
C
Hold
5/29/2015Upgraded
MedX Health Corp (MDX.V) was upgraded to C from C- on 5/29/2015 due to a large increase in the growth index and valuation index. Operating cash flow increased 1,085.45% from -$5.5 to -$65.2, and total revenue increased 33.44% from $180.3 to $240.6.
MedX Health Corp (MDX.V) was upgraded to C from C- on 5/29/2015 due to a large increase in the growth index and valuation index. Operating cash flow increased 1,085.45% from -$5.5 to -$65.2, and total revenue increased 33.44% from $180.3 to $240.6.
C
Hold
3/24/2015Downgrade
MedX Health Corp (MDX.V) was downgraded to C- from C on 3/24/2015 due to a noticeable decline in the growth index, total return index and efficiency index. Earnings per share declined from -$0.0001 to $0.0045, net income declined 3,559.34% from -$9.1 to $314.8, and EBIT declined 222.71% from -$259.4 to $318.3.
MedX Health Corp (MDX.V) was downgraded to C- from C on 3/24/2015 due to a noticeable decline in the growth index, total return index and efficiency index. Earnings per share declined from -$0.0001 to $0.0045, net income declined 3,559.34% from -$9.1 to $314.8, and EBIT declined 222.71% from -$259.4 to $318.3.
